Market Overview:
The global allergy shots market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of allergic diseases, rising awareness about allergy shots, and technological advancements in the field of allergy shots. The global allergy shots market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into sublingual immunotherapy (SLIT), subcutaneous immunotherapy (SCIT), and others. SLIT held a major share in 2017 owing to its advantages such as ease-of-use and patient compliance rates. On the basis of application, the market is divided into allergic rhinitis, allergic asthma, food allergies, atopic dermatitis (AD), and others. AD accounted for a major share in 2017 due to its high prevalence across all regions studied herein.
Product Definition:
Allergy shots, also known as immunotherapy, are treatments that help the body get used to allergens. This is done by giving small doses of the allergen through a shot or by putting it under the tongue.
Sublingual Immunotherapy:
Sublingual immunotherapy is a drug delivery system which involves the active ingredient of the vaccine being placed under the tongue for rapid absorption in to blood stream. The treatment is usually done once every two or three months and it depends on how often patients are allergic to certain foods. This treatment has been around for many years but only recently has it become popular due to its increased safety and efficacy.
Subcutaneous Immunotherapy:
Subcutaneous immunotherapy is a procedure wherein the patient's immune system is activated by injections of allergen extracts. The treatment helps in increasing the antibodies and white blood cells that are responsible for immunity against allergens. This therapy has been used to treat allergies caused due to food, insect bites, drug reactions, and environmental factors among others.
Application Insights:
The allergic rhinitis segment dominated the global allergy shots market in 2017. This can be attributed to the rising prevalence of allergies and environmental pollution. According to a study published by National Center for Biotechnology Information (NCBI) in 2018, it was found that allergic rhinitis affected around 40 million people across the globe.
In addition, according to an article published by NCBI in 2019 titled ¢â‚¬Å“Prevalence of Atopic Dermatitis and Its Relationship With Allergic Rhinitis: A Systematic Review and Meta-analysis¢â‚¬ it was estimated that around 60% of patients with allergic rhinitis are also diagnosed with atopic dermatritis (AD). AD is characterized by chronic skin inflammation due to sensitivity towards various allergens such as dust mites, animal dander etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of food allergies and other allergic disorders, rising consumer awareness about available treatment options, and availability of highly advanced healthcare infrastructure.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure in emerging economies such as India and China. Furthermore, growing medical tourism industry due to affordable treatment options will also boost demand for allergen-specific immunotherapy products in this region.
Growth Factors:
- Increasing prevalence of allergic diseases: The global allergy shots market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing prevalence of allergic diseases such as asthma, rhinitis, and eczema.
- Growing awareness about allergy shots: There is a growing awareness among people about the benefits of allergy shots and this is expected to drive the growth of the market during the forecast period.
- Technological advancements in allergy shot therapies: The development of novel technologies for administering allergy shots is expected to drive market growth during the forecast period. For instance, subcutaneous immunotherapy (SCIT) involves administration of allergen extracts under the skin using very small needles which has led to an increase in its adoption among patients globally. This therapy helps reduce dependence on oral medications and leads to better patient compliance rates as compared with traditional injections administered intramuscularly or intravenously .
Scope Of The Report
Report Attributes
Report Details
Report Title
Allergy Shots Market Research Report
By Type
Sublingual Immunotherapy, Subcutaneous Immunotherapy, Others
By Application
Allergic Rhinitis, Allergic Asthma, Food Allergy, Atopic Dermatitis, Others
By Companies
ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, Arrayit Corporation, Biomay AG, HAL Allergy Group, DBV Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Allergy Shots Market Report Segments:
The global Allergy Shots market is segmented on the basis of:
Types
Sublingual Immunotherapy, Subcutaneous Immunotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergic Rhinitis, Allergic Asthma, Food Allergy, Atopic Dermatitis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALK Abello
- Stallergenes Greer
- Allergy Therapeutics
- Aimmune Therapeutics
- Anergis
- Arrayit Corporation
- Biomay AG
- HAL Allergy Group
- DBV Technologies
Highlights of The Allergy Shots Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sublingual Immunotherapy
- Subcutaneous Immunotherapy
- Others
- By Application:
- Allergic Rhinitis
- Allergic Asthma
- Food Allergy
- Atopic Dermatitis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allergy Shots Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allergy shots are a type of immunotherapy that help to reduce the symptoms of allergies. Immunotherapy involves using medications or other treatments to help your body learn how to fight off allergens on its own. Allergy shots use tiny amounts of allergens, such as pollen, in order to provoke an immune response. This can help reduce the severity and frequency of allergy symptoms.
Some of the major companies in the allergy shots market are ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, Arrayit Corporation, Biomay AG, HAL Allergy Group, DBV Technologies.
The allergy shots market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Allergy Shots Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Allergy Shots Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Allergy Shots Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Allergy Shots Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Allergy Shots Market Size & Forecast, 2018-2028
4.5.1 Allergy Shots Market Size and Y-o-Y Growth
4.5.2 Allergy Shots Market Absolute $ Opportunity
Chapter 5 Global Allergy Shots Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Allergy Shots Market Size Forecast by Type
5.2.1 Sublingual Immunotherapy
5.2.2 Subcutaneous Immunotherapy
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Allergy Shots Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Allergy Shots Market Size Forecast by Applications
6.2.1 Allergic Rhinitis
6.2.2 Allergic Asthma
6.2.3 Food Allergy
6.2.4 Atopic Dermatitis
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Allergy Shots Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Allergy Shots Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Allergy Shots Analysis and Forecast
9.1 Introduction
9.2 North America Allergy Shots Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Allergy Shots Market Size Forecast by Type
9.6.1 Sublingual Immunotherapy
9.6.2 Subcutaneous Immunotherapy
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Allergy Shots Market Size Forecast by Applications
9.10.1 Allergic Rhinitis
9.10.2 Allergic Asthma
9.10.3 Food Allergy
9.10.4 Atopic Dermatitis
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Allergy Shots Analysis and Forecast
10.1 Introduction
10.2 Europe Allergy Shots Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Allergy Shots Market Size Forecast by Type
10.6.1 Sublingual Immunotherapy
10.6.2 Subcutaneous Immunotherapy
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Allergy Shots Market Size Forecast by Applications
10.10.1 Allergic Rhinitis
10.10.2 Allergic Asthma
10.10.3 Food Allergy
10.10.4 Atopic Dermatitis
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Allergy Shots Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Allergy Shots Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Allergy Shots Market Size Forecast by Type
11.6.1 Sublingual Immunotherapy
11.6.2 Subcutaneous Immunotherapy
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Allergy Shots Market Size Forecast by Applications
11.10.1 Allergic Rhinitis
11.10.2 Allergic Asthma
11.10.3 Food Allergy
11.10.4 Atopic Dermatitis
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Allergy Shots Analysis and Forecast
12.1 Introduction
12.2 Latin America Allergy Shots Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Allergy Shots Market Size Forecast by Type
12.6.1 Sublingual Immunotherapy
12.6.2 Subcutaneous Immunotherapy
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Allergy Shots Market Size Forecast by Applications
12.10.1 Allergic Rhinitis
12.10.2 Allergic Asthma
12.10.3 Food Allergy
12.10.4 Atopic Dermatitis
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Allergy Shots Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Allergy Shots Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Allergy Shots Market Size Forecast by Type
13.6.1 Sublingual Immunotherapy
13.6.2 Subcutaneous Immunotherapy
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Allergy Shots Market Size Forecast by Applications
13.10.1 Allergic Rhinitis
13.10.2 Allergic Asthma
13.10.3 Food Allergy
13.10.4 Atopic Dermatitis
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Allergy Shots Market: Competitive Dashboard
14.2 Global Allergy Shots Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ALK Abello
14.3.2 Stallergenes Greer
14.3.3 Allergy Therapeutics
14.3.4 Aimmune Therapeutics
14.3.5 Anergis
14.3.6 Arrayit Corporation
14.3.7 Biomay AG
14.3.8 HAL Allergy Group
14.3.9 DBV Technologies
